Compare XPRO & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XPRO | ATEC |
|---|---|---|
| Founded | 1938 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2013 | 2006 |
| Metric | XPRO | ATEC |
|---|---|---|
| Price | $17.18 | $10.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $15.40 | ★ $22.00 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $522,493,000.00 | $101,739,000.00 |
| Revenue This Year | $4.91 | $18.97 |
| Revenue Next Year | $1.78 | $16.26 |
| P/E Ratio | $37.03 | ★ N/A |
| Revenue Growth | ★ 14.89 | N/A |
| 52 Week Low | $6.70 | $8.82 |
| 52 Week High | $18.73 | $23.29 |
| Indicator | XPRO | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 34.75 |
| Support Level | $15.35 | $10.21 |
| Resistance Level | $18.60 | $11.43 |
| Average True Range (ATR) | 0.77 | 0.57 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 49.59 | 16.80 |
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA); and Asia-Pacific (APAC). The majority of its revenue is derived from the North and Latin America (NLA) segment.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.